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ctopaxin is an actin and paxillin binding protein
that localizes to focal adhesions. It regulates cell
spreading and is phosphorylated during mitosis.
Herein, we identify a role for actopaxin phosphorylation in
cell spreading and migration. Stable clones of U2OS cells
expressing actopaxin wild-type (WT), nonphosphorylatable,
and phosphomimetic mutants were developed to eval-
uate actopaxin function. All proteins targeted to focal adhe-
sions, however the nonphosphorylatable mutant inhibited
spreading whereas the phosphomimetic mutant cells spread
more efﬁciently than WT cells. Endogenous and WT ac-
A
 
topaxin, but not the nonphosphorylatable mutant, were
phosphorylated in vivo during cell adhesion/spreading.
Expression of the nonphosphorylatable actopaxin mutant
signiﬁcantly reduced cell migration, whereas expression of
the phosphomimetic increased cell migration in scrape
wound and Boyden chamber migration assays. In vitro kinase
assays demonstrate that extracellular signal-regulated protein
kinase phosphorylates actopaxin, and treatment of U2OS
cells with the MEK1 inhibitor UO126 inhibited adhesion-
induced phosphorylation of actopaxin and also inhibited
cell migration.
 
Introduction
 
Sites of cell adhesion to the ECM, commonly referred to as
focal adhesions or focal complexes, are important centers of
signal transduction. Through the recruitment of numerous
structural and regulatory proteins to the cytoplasmic tails of
clustered integrin receptors, focal adhesions contribute to
creating physical and functional links between the ECM and
the actin cytoskeleton thereby regulating many important
cellular processes including migration, proliferation, and
survival (Clark and Brugge, 1995; Giancotti and Ruoslahti,
1999; Hynes, 2002).
Cell migration is a multistep process (Lauffenburger and
Horwitz, 1996). A major driving force of motility is the for-
mation of a leading edge protrusion and extension of a
lamellipodium, followed by the establishment of new focal
adhesion sites at the front of the cell and detachment of
adhesions at the rear. These events require the dynamic re-
organization of the actin cytoskeleton and the turnover of
focal adhesions (Lauffenburger and Horwitz, 1996; Horwitz
and Parsons, 1999; Totsukawa et al., 2004; Webb et al.,
2004). A diverse range of signaling molecules have been
implicated in coordinating these events including the Rho
family of GTPases and their numerous effectors such as the
p21-activated kinase (PAK), Rho kinase, and N-WASP
(Takenawa and Miki, 2001; Bokoch, 2003; Raftopoulou
and Hall, 2004); that, in turn, target key actin regulators to
control actin filament assembly and actomyosin contractility
(Brahmbhatt and Klemke, 2003; Totsukawa et al., 2004).
Focal adhesion proteins such as FAK and paxillin also perform
an important adaptor function and are essential for normal
focal adhesion turnover (Turner, 2000; West et al., 2001;
Webb et al., 2004).
The MAPK extracellular signal-regulated protein kinase
(Erk) also localizes to focal adhesions, potentially through an
interaction with paxillin (Ishibe et al., 2003). Erk contributes
to the regulation of cell migration through activation of
myosin light chain kinase (MLCK) and subsequent phos-
phorylation of myosin light chain (Klemke et al., 1997) to
stimulate localized myosin-based contractility, membrane
ruffling, and focal adhesion turnover (Klemke et al., 1997;
Brahmbhatt and Klemke, 2003; Totsukawa et al., 2004; Webb
et al., 2004). Erk also facilitates focal adhesion disassembly
and thus cell retraction at the rear, in part through phos-
phorylation and activation of the protease Calpain (Bhatt et
al., 2002; Carragher et al., 2003).
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Actopaxin, also known as 
 
 
 
-parvin/CH-ILKBP, is a fo-
cal adhesion protein that interacts with actin, paxillin, and
the integrin-linked kinase (ILK; Nikolopoulos and Turner,
2000, 2002; Olski et al., 2001; Tu et al., 2001; Yamaji et al.,
2001). Actopaxin is composed of an amino terminus of 95
aa followed by two calponin homology (CH) domains. A
functional role for the tandem CH domains in F-actin bind-
ing has been confirmed (Nikolopoulos and Turner, 2000;
Olski et al., 2001). The CH2 domain of actopaxin also con-
tains the ILK and paxillin binding subdomain (PBS; Niko-
lopoulos and Turner, 2000, 2002; Tu et al., 2001). Consis-
tent with a role for actopaxin in actin-mediated cellular
processes, overexpression of actopaxin mutants defective for
either paxillin- or actin-binding results in impaired cell ad-
hesion and cell spreading (Nikolopoulos and Turner, 2000,
2002; Tu et al., 2001; Yamaji et al., 2001).
Although lacking any obvious tertiary structure, the amino
terminus of actopaxin is phosphorylated by the cyclinB/cdc2
kinase during entry into mitosis (Curtis et al., 2002). Phos-
phorylation of actopaxin, like other focal adhesion and cyto-
skeletal proteins such as FAK, paxillin, caldesmon, and PAK,
likely contributes to the pre-mitotic disassembly of focal adhe-
sions associated with cell rounding and/or cell re-spreading af-
ter cytokinesis (Yamaguchi et al., 1997; Yamashiro et al.,
2001; Curtis et al., 2002; Thiel et al., 2002). However, a
functional role for actopaxin phosphorylation in the regula-
tion of other cellular processes requiring cytoskeletal remodel-
ing, such as cell migration, has not been previously evaluated.
Here, we have determined that the actopaxin amino ter-
minus is phosphorylated in response to cell adhesion. Using
nonphosphorylatable and phosphomimetic mutants of acto-
paxin we demonstrate that actopaxin phosphorylation is re-
quired for cell spreading, lamellipodia formation, and cell
migration. In addition, the MAPK Erk phosphorylates the
amino terminus of actopaxin and pharmacologic inhibition
of MEK1, the upstream regulator of Erk, inhibited both ac-
topaxin phosphorylation and cell migration. Together, these
results identify actopaxin phosphorylation as a new and crit-
ical component of the cell migration machinery.
 
Results
 
Actopaxin phosphorylation is stimulated during 
cell spreading
 
Actopaxin is composed of an amino terminus of 95 aa fol-
lowed by two CH domains. The CH domains function as
binding sites for F-actin, paxillin, and ILK. The amino termi-
nus lacks any obvious tertiary structure. However, it contains
several phosphorylation consensus sites for cyclinB/cdc2 that
are targeted during mitosis (Fig. 1), suggesting that this re-
gion of actopaxin may serve a regulatory function associated
with the rearrangement of the actin cytoskeleton and/or the
disassembly of focal adhesions that accompany progression
through mitosis. A similar role for actopaxin phosphorylation
in regulating other cellular processes involving dynamic reor-
ganization of the cytoskeleton such as cell adhesion/spreading
and motility has not previously been investigated.
Actopaxin phosphorylation was examined during cell ad-
hesion and spreading of human osteosarcoma (U2OS) cells.
Cells were in vivo labeled with inorganic 
 
32
 
P, harvested, and
either held in suspension or re-spread on a collagen matrix
for 2 h. Endogenous actopaxin was immunoprecipitated and
visualized by autoradiography. Actopaxin phosphorylation
was significantly enhanced in the adherent/spreading cell
population (Fig. 2, lane 2) as compared with cells retained in
suspension (Fig. 2, lane 1). Analysis of the cell lysates indi-
cated identical levels of 
 
32
 
P-incorporation (Fig. 2, lanes 3 and
4). Paxillin phosphorylation was also stimulated during cell
spreading, consistent with previous reports (Fig. 2, lanes 1
and 2; Bellis et al., 1997). These data demonstrate that acto-
paxin phosphorylation is not restricted to mitotic events, and
suggested a role in cell adhesion, spreading, and migration.
 
Adhesion-mediated phosphorylation of actopaxin is 
restricted to the amino terminus
 
To evaluate the role of actopaxin phosphorylation in regulat-
ing cell adhesion and spreading, clonal U2OS cell lines express-
ing Xpress-tagged full-length actopaxin wild-type (WT) acto-
paxin and an actopaxin phosphorylation mutant were generated.
The amino terminus of actopaxin contains four serine/proline
phosphorylation sites and one threonine/proline site (Fig. 1),
previously shown to be phosphorylated by cyclin B/cdc2
(Curtis et al., 2002). Taking these data into consideration,
we generated a quintuple (Quint) nonphosphorylatable mu-
Figure 1. Actopaxin domain structure and phosphorylation sites. 
The domain schematic illustrates the relative positions of the two 
calponin homology (CH) domains, ILK, and PBS, and the principal 
cyclin B/cdc2 phosphorylation sites. The amino-terminal amino 
acid sequence indicates the location of the five potential phosphor-
ylation sites (S4, 8, 14, 19, and T16) targeted in the current work.
Figure 2. Actopaxin is phosphorylated in vivo after cell adhesion. 
Cells were labeled with inorganic 
32P and either held in suspension 
(lanes 1 and 3) or spread on collagen I–coated dishes for 2 h (lanes 
2 and 4). Actopaxin (top) and paxillin (bottom) proteins were immuno-
precipitated, resolved on SDS-PAGE, and visualized by autoradi-
ography. WCL, whole cell lysate. 
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tant of actopaxin in which each of the serine phosphorylation
sites were changed to glycine and the threonine was changed
to alanine (S(4,8,14,19)G/T16A). Sites were not mutated
individually because previous studies indicated that this po-
tentially contributes to phosphorylation of cryptic sites
(Curtis et al., 2002). The Quint and WT proteins were then
evaluated for their ability to be phosphorylated during cell
adhesion using in vivo 
 
32
 
P-labeling assays as described above.
As was observed with endogenous actopaxin, Xpress-WT
actopaxin was phosphorylated in response to cell adhesion/
spreading (Fig. 3 A, lanes 1 and 2), whereas the Quint acto-
paxin mutant was not phosphorylated (Fig. 3 A, lanes 3 and
4). Immunoprecipitation of the WT and Quint proteins
demonstrated that both are expressed and immunoprecipi-
tated at similar levels (Fig. 3 B). These data confirmed that
actopaxin is phosphorylated in response to cell adhesion/
spreading in asynchronously growing cell populations, and
that the sites targeted for the phosphorylation are confined
to the amino terminus of actopaxin and are eliminated in
the Quint actopaxin mutant.
 
Actopaxin phosphorylation mutants localize to focal 
adhesions and affect cell morphology
 
The first two amino-terminal (4/8) serine/proline sites are
the primary sites of mitotic phosphorylation, contributing to
the electrophoretic mobility shift of actopaxin in that system
(Curtis et al., 2002). We hypothesized that phosphorylation
of the S4/8 sites may also be a significant component of the
Figure 3. Quint mutant of actopaxin is not phos-
phorylated upon adhesion/spreading. (A) WT 
actopaxin (WT) and a nonphosphorylatable mutant 
(Quint) of actopaxin were stably expressed in U2OS 
cells. WT and Quint clone cells were labeled with 
inorganic 
32P and either held in suspension (lanes 
1 and 3) or spread on collagen-coated dishes for 2 h 
(lanes 2 and 4). Xpress tagged WT and Quint acto-
paxin proteins were immunoprecipitated, resolved 
on SDS-PAGE, and visualized by autoradiography. 
WCL are shown to indicate equivalent labeling. 
(B) Parental U2OS, WT, and Quint cells were spread 
on collagen and Xpress-tagged WT and Quint 
actopaxin proteins were immunoprecipitated and 
visualized by Western blotting. The same blot was 
probed with  -actinin antibodies to indicate equiv-
alent loading.
Figure 4. Expression of actopaxin phosphorylation 
mutants does not affect localization to focal 
adhesions. (A) Western blot of U2OS parental, 
WT, Quint, and S4/8D cells probed with an anti-
Xpress–tagged antibody to confirm their equal 
expression. The same blot was stripped and reprobed 
with actopaxin and  -actinin antibodies to visualize 
endogenous actopaxin and to indicate equivalent 
loading. (B) Immunofluorescence staining of parental 
(a), WT (b), Quint (c), and S4/8D (d) cells with anti-
Xpress antibody to detect transfected actopaxin 
and rhodamine phalloidin (e–h) to visualize actin 
stress fibers. Micrographs were merged to demon-
strate localization of actopaxin WT, Quint, and 
S4/8D to focal adhesions at the ends of actin stress 
fibers (j–l). Bar, 2  m. 
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adhesion-induced phosphorylation of actopaxin. Thus, we
constructed a phosphomimetic, S4/8D, mutant and gener-
ated stable U2OS cell lines expressing this mutant. Western
blot analysis confirmed equal levels of expression of each ac-
topaxin construct in the three clonal cell lines used in the
functional analyses detailed below (Fig. 4 A, top). We esti-
mate that the exogenous actopaxin is expressed at 
 
 
 
2–3
times that of the endogenous protein.
Cell spreading is accompanied by the formation of focal
adhesions and reorganization of the actin cytoskeleton,
thus the organization of these structures was evaluated in
the actopaxin-expressing cells by indirect immunofluores-
cence. Parental, WT, Quint, and S4/8D cells were har-
vested and allowed to spread overnight on glass coverslips
in complete growth medium. Xpress WT, Quint, and S4/
8D actopaxin mutants all localized effectively to focal ad-
hesions as determined by labeling with anti-Xpress anti-
body (Fig. 4 B, b–d). Cells were simultaneously stained
with rhodamine phalloidin to visualize F-actin, and to as-
sess possible changes in the organization of the actin cyto-
skeleton resulting from the overexpression of actopaxin
phosphorylation mutants (Fig. 4 B, e–h). Parental and WT
cells exhibited similar actin organization (Fig. 4 B, e and f).
In contrast, the Quint cells exhibited more robust actin
staining (Fig. 4 B, g), whereas the S4/8D cells developed
very fine actin stress fibers (Fig. 4 B, h). Merged images
demonstrate localization of Xpress-tagged actopaxin to the
ends of actin stress fibers (Fig. 4 B, i–l). To ensure that the
results were not due to a clonal phenomenon, WT, Quint,
and S4/8D were transiently expressed in U2OS cells. Addi-
tional stable clones were also evaluated. Analysis of these
cells under the conditions detailed above yielded similar re-
sults (unpublished data).
 
Actopaxin phosphorylation is required for normal
cell spreading
 
In view of the correlation between actopaxin phosphorylation
and spreading we evaluated the kinetics of spreading for the
Figure 5. Actopaxin phosphorylation mutants 
affect cell spreading. Actopaxin WT, Quint, and 
S4/8D cells were plated on collagen type 1–coated 
dishes and evaluated by time-lapse video micros-
copy. (A) Representative Hoffman illumination 
images were acquired at 45, 90, and 150 min after 
plating. Quint cells are poorly spread and lack 
lamellipodia at all time points (d-f) compared with 
WT (a–c), whereas the S4/8D cells demonstrate 
enhanced spreading (g–i). Bar, 5  m. (B) Quantita-
tion of cell area during spreading. Parental, WT, 
Quint, and S4/8D cells were plated on collagen 
coated slips for 30, 60, 120, and 240 min. For 
each time point, slips were fixed and processed 
for indirect immunofluorescence. Total cell area 
was then calculated from the images. Data repre-
sent the mean   SD of at least 100 cells from three 
separate experiments for each time point. 
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WT and mutant actopaxin-expressing cells. Parental, WT,
Quint, and S4/8D cells were harvested and replated on col-
lagen type I–coated culture dishes in serum-free conditions.
Cells were evaluated over a 4-h time course by time-lapse
video microscopy. Hoffman modulation contrast images of
WT, Quint, and S4/8D cells spreading at 45, 90, and 150
min are presented in Fig. 5 A. Parental U2OS cells demon-
strated a similar phenotype to the WT cells (unpublished
data). In contrast, the Quint cells were severely impaired in
their ability to spread compared with WT at each of the time
points (Fig. 5 A; compare a–c with d–f), whereas the S4/8D
cells exhibited greatly enhanced spreading (Fig. 5 A, g–i). In
addition, as cell spreading progressed the WT and S4/8D
cells matured to form a polarized phenotype, exhibiting a
dominant lamellipodium. However, the Quint cells extended
multiple randomly oriented protrusions and failed to develop
a dominant lamellipodium at any of the time points exam-
ined (Fig. 5 A; compare d–f with a–c; Videos 1–3, available at
http://www.jcb.org/cgi/content/full/jcb.200404024/DC1).
In a parallel analysis, quantitation of cell area during the
spreading time course on a collagen matrix confirmed the
differences in spreading, with WT equivalent to parental,
Quint at 50% of parental and the S4/8D cells at 
 
 
 
175% of
the WT/parental populations at each time point examined
(Fig. 5 B). Interestingly, analysis of the spreading time-lapse
also suggested a significant defect in cell migration of the
Quint cells compared with the WT and S4/8D (compare
Video 2 with Videos 1 and 3). Together, these data suggest
that actopaxin phosphorylation plays a critical role in adhe-
sion-mediated cell signaling events.
 
Actopaxin phosphorylation mimics Rac activation
 
The Rho GTPases play important roles in the dynamics of
cell spreading. Rho regulates cell contractility and stress fi-
ber formation, whereas Rac promotes lamellipodia formation
(Raftopoulou and Hall, 2004). The results presented above
suggest a close connection between actopaxin phosphoryla-
tion and Rac signaling with the Quint cells potentially inhib-
iting Rac activity, whereas the morphology of the S4/8D cells
suggests actopaxin phosphorylation is downstream of Rac. To
examine this further, WT, Quint, and S4/8D cells were tran-
siently transfected with dominant negative N17 Rac and
GFP. Cells were fixed, costained with rhodamine phalloidin
to visualize F-actin and GFP positive cells were evaluated for
potential changes in morphology. WT actopaxin cells express-
ing the N17 Rac exhibited a reduced capacity to form lamelli-
podia (Fig. 6, A and B), whereas the morphology of the Quint
cells was unaffected. Interestingly, the S4/8D cells were signif-
icantly more resistant than the WT cells to N17 Rac and were
able to maintain their lamellipodia (Fig. 6, A and B) suggest-
ing that the phospho-mimetic S4/8D is indeed functioning as
a Rac effector. GST-PBD experiments were also performed to
evaluate overall Rac activity in each of the cell lines. However,
the results were inconclusive since total Rac activity was un-
changed suggesting that localized regulation of Rac activity/
function is critical in U2OS cells (unpublished data).
 
Actopaxin phosphorylation regulates cell migration
 
Dynamic phosphorylation of cytoskeletal proteins is essen-
tial for effective cell motility. To evaluate the role of acto-
paxin and its phosphorylation in cell migration, wound as-
says were performed using parental, WT, Quint, and S4/8D
cells. The rate of wound closure was assessed over a 12-h
time period. The parental and WT cells closed the wound at
similar rates (19.5 and 19.7 
 
 
 
m/h, respectively; Fig. 7 A, a,
e, i, and b, f, j). The Quint cells migrated at a rate of 11.5
Figure 6. Actopaxin phosphorylation mimics Rac activity. WT, 
Quint, and S4/8D clones plated on glass coverslips were cotransfected 
with dominant negative N17 Rac (DN Rac) and GFP for 24 h. (A) 
After transfection, slips were fixed and processed for indirect immuno-
fluorescence. Actin stress fibers were visualized by staining with 
rhodamine phalloidin. Bar, 5  m. (B) Quantitation of lamellipodia 
formation in WT, Quint, and S4/8D transfected cells cotransfected 
with DN Rac was accomplished by counting GFP positive cells and 
compared with control nontransfected cells. The presence of at 
least one broad lamellipodia on a cell was counted as positive. 
Note that cells expressing the S4/8D actopaxin mutant were more 
resistant to inhibition of lamellipodia formation than the WT cells 
suggesting phosphorylation of actopaxin is downstream of Rac. 
Percentages are representative of three separate experiments and 
a total of 300 cells. 
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m/hr, 
 
 
 
40% slower than both WT and parental (Fig. 7 A,
c, g, k). In contrast, the S4/8D cells demonstrated an in-
creased ability to close the wound with a rate of 26.0 
 
 
 
m/h,
approaching 133% of parental (Fig. 7 A, d, h, l).
The wound edge was evaluated by immunofluorescence
microscopy to characterize alterations in cell morphology and
actin cytoskeleton during wound closure (Fig. 7 B). In con-
trast to the other cell lines, the S4/8D cells rapidly (within 1
h) extended broad lamellipodia into the open wound (Fig. 7
B, a–d). 4 h after wounding, the parental and WT cells also
developed a leading edge similar to the S4/8D cells; however,
the Quint cells exhibited only minimal protrusions at the
wound edge even after 4 h (Fig. 7 B, e–h). These results corre-
late with the morphology exhibited during cell spreading (Fig.
5) and demonstrate an important role for actopaxin phos-
phorylation in lamellipodial extension and cell migration.
To extend the wound closure analysis, modified Boyden
chamber migration assays were performed to evaluate addi-
tional aspects of motility including haptotaxis, chemokine-
sis, and chemotaxis. To evaluate haptotaxis, cells migration
toward immobilized collagen or fibronectin was measured
(Fig. 8 A). Chemokinesis and chemotaxis were evaluated in
response to insulin-like growth factor (IGF) II (Fig. 8 B).
Consistent with the wound data, the S4/8D cells migrated
more efficiently than either the parental or WT cells,
whereas the Quint cells exhibited significantly reduced mi-
gration rates under all conditions tested (Fig. 8, A and B).
Together, these data indicate inhibition of actopaxin phos-
phorylation inhibits cell migration, whereas a phosphomi-
metic promotes motility.
 
Erk phosphorylates the actopaxin amino terminus
 
The five actopaxin phosphorylation sites conform to the con-
sensus for Erk in addition to cdc2. Interestingly, Erk can lo-
calize to focal adhesions possibly through an association with
paxillin (Ishibe et al., 2003) and has been directly linked to
regulating cell motility (Klemke et al., 1997). Thus, Erk me-
diated phosphorylation of actopaxin provides a potential
mechanism to explain our spreading and motility observa-
tions. To evaluate actopaxin as a potential target for Erk ki-
nase activity, GST-fusion proteins of full-length actopaxin,
its amino terminus, and its carboxyl terminus were incu-
bated with active Erk2. Erk phosphorylated full-length ac-
topaxin (amino acids 1-372), and fusion proteins encompass-
ing amino-terminal amino acids 1-222 and 1-95 (Fig. 9 A,
lanes 1, 2, and 4). However, Erk did not phosphorylate the
carboxyl terminus (222-372) of actopaxin (Fig. 9 A, lane 3).
To evaluate a potential role for Erk in actopaxin phos-
phorylation in vivo, adhesion-induced phosphorylation of
actopaxin was evaluated in the absence or presence of the
MEK1 inhibitor UO126. The addition of the MEK1 in-
hibitor resulted in a substantial reduction in the level of ad-
Figure 7. Expression of actopaxin phos-
phorylation mutants interferes with 
wound closure. Scrape wound assays 
were performed using U2OS parental 
and actopaxin WT, Quint, and S4/8D 
cells. Cells were plated in complete 
media at a confluent density and scored 
with a micropipette tip. (A) Hoffman 
images were taken at 0, 6, and 12 h after 
wounding, and average wound closure 
rates are shown. Quint cells have reduced 
closure rates compared with parental 
and WT cells, whereas S4/8D cells 
demonstrated an enhanced closure 
rate. Average rates of closure were cal-
culated from three separate experiments. 
(B) Analysis of cell morphology at the 
wound edge. Parental, WT, Quint, and 
S4/8D cells were plated on coverslips 
and wounded as above. Slips were 
processed for indirect immunofluores-
cence at 1 and 4 h after wounding. Cells 
were stained with rhodamine phalloidin 
to visualize actin stress fibers. Quint 
cells at the wound edge lacked significant 
lamellipodia (e and f) as compared with 
parental and WT cells (a–d). S4/8D cells 
demonstrated enhanced lamellipodia 
formation (g and h). Bar, 5  m. 
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hesion induced actopaxin phosphorylation of both the en-
dogenous and exogenous protein, whereas incorporation of
 
32
 
P into total cellular proteins was unaffected by the addi-
tion of the MEK1 inhibitor (Fig. 9 B). To compliment the
inhibitor studies, WT actopaxin and either active MEK1
(MEK1) or dominant-negative MEK1 (DN MEK1) were
cotransfected into parental U2OS cells followed by in vivo
 
32
 
P-labeling in the absence or presence of UO126. Impor-
tantly, DN MEK1 inhibited the adhesion-induced phos-
phorylation of actopaxin when compared with cells express-
ing the active MEK1 (Fig. 9 C). Together, these results
demonstrate that actopaxin is a target for Erk phosphoryla-
tion and suggest that Erk may contribute to actopaxin
phosphorylation during cell spreading.
 
Erk inhibition impedes U2OS cell migration 
and actopaxin phosphorylation mutants are 
differentially affected
 
Wound healing and Boyden chamber assays were used to
characterize the role of Erk in actopaxin-mediated cell migra-
tion. The inclusion of the MEK1 inhibitor UO126 during
wound healing attenuated the closure rates of each of the cell
populations (parental, WT, Quint, and S4/8D) indicating
an important role for Erk in promoting cell motility in
U2OS osteosarcoma cells, but raising the formal possibility
that Erk phosphorylation of actopaxin may not play a major
role in cell migration during wound healing. Interestingly
however, the S4/8D cells still exhibited the highest motility
rate (Fig. 10, A and B) suggesting phosphorylation of these
sites contributes to Erk-dependent migration. Similar results
Figure 8.  Actopaxin phosphorylation mutants affect Boyden 
chamber migration.  Motility of parental, WT, Quint, and S4/8D 
cells was evaluated by modified Boyden chamber migration assays. 
(A) Quantification of random (haptotaxis) motility to collagen (10 
µg/ml) or fibronectin (10 µg/ml) demonstrates significant reduction 
in Quint cell migration as compared with parental and WT cells, 
whereas S4/8D cells show an increase in migration. (B) Quantifi-
cation of chemokinesis and chemotaxis in the presence of IGF-II 
(25 ng/ml) demonstrates a similar trend for each cell line to that 
seen in the haptotaxis assays. Values are the average of assays 
performed in triplicate.
Figure 9. Erk phosphorylates the actopaxin amino terminus in vitro. 
(A) GST actopaxin fusion proteins were incubated with active ERK2. 
Fusion proteins were resolved by SDS-PAGE and phosphorylated 
proteins were visualized by autoradiography. Phosphorylation is 
apparent on WT (full length) and the amino terminus (1-222 and 
1-95) of actopaxin, but not on the carboxyl terminus (223-372). 
Coomassie blue-stained gel is shown to demonstrate expression 
of the fusion proteins. (B) In vivo inhibition of actopaxin phosphory-
lation in the presence of the Erk inhibitor UO126. Xpress-actopaxin 
WT cells labeled with 
32P were held in suspension, or re-spread on 
collagen-coated dishes for 120 min in the presence or absence of 
UO126 (25  M) followed by immunoprecipitation, SDS-PAGE, and 
autoradiography. Adhesion induced actopaxin phosphorylation 
(lane 2) is reduced in the presence of UO126 (lane 3). (C) Actopaxin 
WT cells were transfected with active MEK1 or DN MEK1. Cells 
labeled with 
32P were re-spread on collagen-coated dishes for 120 
min in the presence or absence of UO126 (25  M). Xpress-tagged 
WT actopaxin was immunoprecipitated followed by analysis by 
SDS-PAGE and autoradiography. 
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were also observed with the addition of another MEK1 in-
hibitor PD98059 (unpublished data). Of note, careful evalu-
ation of the wound edge revealed that at the later time points
the S4/8D cells were still able to extend broad lamellipodia
into the wound in the presence of the inhibitor, whereas the
development of a leading edge in the other cell lines was im-
paired (unpublished data). Importantly, although actopaxin
can be phosphorylated by cyclinB/cdc2 during mitosis and a
recent report identified a role for cyclinB/cdc2 in 
 
 
 
v
 
 
 
3
 
 inte-
grin-dependent migration (Manes et al., 2003), wound clo-
sure was not inhibited in any of the cell lines in the presence
of the cdc2 inhibitor alsterpaullone (Fig. 10 B) or another
cdc2 inhibitor purvalanol-A (not depicted).
We also evaluated the relative role of cdc2 versus Erk
activity in regulating U2OS cell haptotaxis by performing
Boyden chamber assays in the presence of the cdc2 inhibitor
alsterpaullone or the MEK1 inhibitor UO126. As was the
case with the wound assay, no significant inhibition of col-
Figure 10.  Inhibition of Erk but not cyclin B/cdc2 
decreases cell migration in U2OS cells. Scrape 
wound assays were performed using parental, 
actopaxin WT, Quint, and S4/8D cells in the pres-
ence of Erk or cyclin B/cdc2 inhibitors. Cultures 
were incubated for 2 h with MEK1 inhibitor UO126 
(25  M) to inhibit Erk or alsterpaullone (1  M) to 
inhibit cdc2, scored with a micropipette tip, and 
provided with fresh complete media plus inhibitor. 
(A) Hoffman illumination images taken at 0, 6, and 
12 h after wounding in the presence of U0126 are 
depicted. (B) Quantitation of wound closure rates 
of parental, WT, Quint, and S4/8D cells in the 
presence of UO126 or alsterpaullone. (C) To evaluate 
the effect of MEK1 or cdc2 inhibition on random 
motility (haptotaxis), modified Boyden chamber 
migration assays to collagen I (10  g/ml) were 
performed with or without UO126 (25  M) or 
alsterpaullone (1  M). Values are the average of 
three experiments. 
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lagen I haptotaxis was recorded in the presence of the cdc2
inhibitor (Fig. 10 C). In contrast, U0126 inhibited migra-
tion of the parental, WT, and S4/8D actopaxin cell lines.
Interestingly, in this assay the Quint cells, although exhibit-
ing the slowest rate of migration, were essentially unaffected
by the MEK1 inhibitor, suggesting that this basal motility
rate is Erk-independent and that actopaxin phosphorylation
is important for Erk-mediated motility in this context.
 
Discussion
 
Actopaxin was first identified as a paxillin and actin bind-
ing protein (Nikolopoulos and Turner, 2000; Olski et al.,
2001). The interaction with paxillin is essential for targeting
actopaxin to focal adhesions (Nikolopoulos and Turner,
2000). Consistent with a role for actopaxin in actin-medi-
ated cellular processes, introduction of actopaxin mutants
defective for either paxillin- or actin-binding results in im-
paired cell adhesion and cell spreading (Nikolopoulos and
Turner, 2000; Tu et al., 2001; Yamaji et al., 2001). Al-
though actopaxin is a major target for phosphorylation by
the cyclinB/cdc2 kinase during mitosis (Curtis et al., 2002),
the potential for actopaxin to serve as a kinase substrate in
other cellular processes has not been previously evaluated.
Here, we have determined that actopaxin phosphorylation is
stimulated during cell adhesion and, using nonphosphory-
latable and phosphomimetic mutants of actopaxin, we have
determined that actopaxin phosphorylation plays a critical
role in the regulation of cell spreading and cell migration,
potentially as an effector of Rac activity. Furthermore, we
present evidence that actopaxin is directly phosphorylated
by the MAPK Erk in vitro and actopaxin phosphorylation is
dependent on Erk activity in vivo, thereby identifying acto-
paxin as a key substrate for this important regulator of cell
migration (Klemke et al., 1997; Brahmbhatt and Klemke,
2003; Webb et al., 2004).
Cell adhesion to the ECM initiates a series of integrin-medi-
ated intracellular signaling events that promotes cell spread-
ing via the formation of filopodia and broad lamellipodia.
This process, which involves the initial activation of Cdc42
and Rac GTPases (Price et al., 1998) followed subsequently
by an elevation in Rho GTPase activity, closely resembles the
membrane and actin cytoskeletal remodeling events that oc-
cur in a motile cell as it extends and then stabilizes its leading
edge (Nobes and Hall, 1999; Ridley, 2001). Using this cell
spreading assay we were able to demonstrate for the first time
that actopaxin phosphorylation is stimulated during cell ad-
hesion. Furthermore, similar experiments with cells stably ex-
pressing a nonphosphorylatable (Quint) mutant of actopaxin
revealed a significant role for actopaxin phosphorylation in
promoting cell spreading. Importantly, these cells were defi-
cient in their ability to extend and stabilize lamellipodia. This
defect was also evident when analyzing cell membrane dy-
namics at a newly formed wound edge. Although the parental
and WT actopaxin expressing cells rapidly extended a broad
lamellipodium into the area of the wound denuded of cells,
the actopaxin Quint mutant cells were unable to do so. Con-
versely, a putative phosphomimetic mutant of actopaxin, S4/
8D, stimulated cell spreading and also enhanced lamellipodia
formation at the wound edge. Additionally, overexpression of
dominant negative N17 Rac failed to effectively block lamel-
lipodia formation in the majority of the S4/8D mutant cells,
whereas a significant reduction of lamellipodia was evident in
the WT cells. Together, these results suggest that actopaxin
phosphorylation functions either downstream or parallel to
Rac activation, whereas unphosphorylated actopaxin may in-
hibit Rac activity and promote Rho signaling and the forma-
tion of actin stress fibers. Future studies will be required to
fully delineate the impact of actopaxin phosphorylation on
Rho GTPase family signaling.
Although the mechanism is currently unknown, it is inter-
esting to speculate on how phosphorylation of actopaxin
could impact Rho GTPase signaling. One potential link is
through PIX. The PIX/COOL proteins have been shown to
exhibit guanine nucleotide exchange factor activity toward
Cdc42 and Rac1 (Cerione, 2004). Recent studies have dem-
onstrated that the actopaxin family member 
 
 
 
-parvin/affixin
(Yamaji et al., 2002), interacts with and localizes with 
 
 
 
-PIX
at the leading edge of spreading cells (Olski et al., 2001;
Rosenberger et al., 2003). In addition to this direct interac-
tion, PIX isoforms also could be brought into close proximity
to actopaxin in focal adhesions through their shared ability to
interact with paxillin; actopaxin via a direct association (Ni-
kolopoulos and Turner, 2000; Tumbarello et al., 2002) and
PIX via association with the ARFGAP, PKL/GIT2, which in
turn binds the LD4 motif of paxillin (Turner et al., 1999;
Zhao et al., 2000; Brown et al., 2002). Whether actopaxin
phosphorylation imparts allosteric changes that directly affect
the actopaxin-PIX association and/or PIX binding to PAK,
to regulate the targeting of PIX; or instead influences PIX
guanine nucleotide exchange factor activity to activate PAK
stimulation of membrane ruffling through PAK phosphory-
lation of MLCK/MLC and filamin (Kiosses et al., 1999;
Vadlamudi et al., 2002) will require further study.
Alternatively, because actopaxin can bind F-actin directly
via its tandem CH domains (Nikolopoulos and Turner,
2000), actopaxin phosphorylation may perform a more di-
rect role in influencing actin filament assembly at the lead-
ing edge of motile cells. A key component in this process is
the Arp2/3 complex, which binds to the side of a preexisting
actin filament and nucleates new filament assembly resulting
in the formation of branched networks of actin filaments at
the cell cortex (Svitkina and Borisy, 1999); a process that has
been shown to be essential for lamellipodial extension (Bailly
et al., 2001). Recently, the Arp2/3 complex was found to
bind vinculin in focal adhesions and proposed as a mecha-
nism for delivering Arp2/3 into close proximity with its acti-
vators at the leading edge such as N-WASP, which in turn
could be activated via PIX stimulated cdc42 activation (De-
Mali and Burridge, 2003; Cerione, 2004; Etienne-Manne-
ville, 2004). Because vinculin and actopaxin both bind paxil-
lin (Nikolopoulos and Turner, 2000; Turner, 2000) it will
be of interest to determine if actin binding to actopaxin is
regulated by phosphorylation as has been shown for other
actin binding proteins such as caldesmon, filamin and tro-
pomyosin (Vadlamudi et al., 2002; Houle et al., 2003;
Huang et al., 2003; Yamakita et al., 2003) and if actopaxin
is directly involved in Arp2/3-associated actin remodeling.
Another intriguing connection with the actin cytoskeleton
that may be regulated through actopaxin phosphorylation in- 
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volves the interaction between actopaxin and the integrin-
linked kinase (ILK). First identified as an integrin binding
protein, ILK has been implicated in a plethora of cell signal-
ing events associated with cell transformation, migration, me-
tastasis, matrix assembly, and cell survival (Wu and Dedhar,
2001). Importantly, a cassette of proteins comprising ILK-acto-
paxin-PINCH and in some cases paxillin, has emerged as an
evolutionarily conserved integrin-actin linkage in organisms
as diverse as humans, worms, and flies. Elimination of indi-
vidual components of this cassette results in defective inte-
grin-actin attachment in muscle tissue in 
 
C. elegans
 
 and 
 
D.
melanogaster
 
, whereas gene knockout of ILK in mice causes
embryonic lethality and severe adhesion/spreading defects
in cells derived from these embryos (Zervas et al., 2001;
Mackinnon et al., 2002; Brakebusch and Fassler, 2003; Lin
et al., 2003; Sakai et al., 2003). Thus, actopaxin phosphory-
lation could prove important in regulating these interactions
and stabilizing integrin linkage to the cytoskeleton. In this re-
gard, the actopaxin family member affixin, can be phosphor-
ylated by ILK in vitro (Yamaji et al., 2001), although the site
of phosphorylation resides in the CH2 domain, rather than
the amino terminus (Mishima et al., 2004).
The Erk MAPK cascade has been implicated in the regula-
tion of cell migration on several levels. First its activity can
be stimulated via integrin mediated activation of FAK/Src
(Hauck et al., 2002) and also after association with paxillin,
which likely also contributes to the recruitment of Erk to fo-
cal adhesions (Fincham et al., 2000; Ishibe et al., 2003). The
paxillin binding protein PAK also contributes to Erk activa-
tion via phosphorylation of its upstream regulators Raf and
MEK1 (Slack-Davis et al., 2003). Paxillin-null mice are de-
fective in Erk activation and exhibit motility defects (Hagel
et al., 2002) that are consistent with a recent report detailing
the importance of Erk activation and paxillin in focal ad-
hesion turnover (Webb et al., 2004). Erk mediates cell mi-
gration via regulation of MLCK at the leading edge to pro-
mote myosin II-based contractility and membrane ruffling
(Klemke et al., 1997; Brahmbhatt and Klemke, 2003; Tot-
sukawa et al., 2004). It also facilitates focal adhesion disas-
sembly and thus cell retraction at the rear through phos-
phorylation and activation of the protease Calpain (Bhatt et
al., 2002; Carragher et al., 2003; Cuevas et al., 2003). Our
in vitro kinase data indicate that the actopaxin amino termi-
nus represents a bona fide target for Erk kinase activity.
Clearly, actopaxin, through binding paxillin in focal adhe-
sions is optimally positioned adjacent to active Erk to serve
as a substrate. A physiologic role for Erk-mediated phos-
phorylation of actopaxin in regulating cell migration is sup-
ported by our results showing that MEK1 inhibitors and
dominant negative MEK1 block adhesion-induced phos-
phorylation of actopaxin and also effectively block cell
migration in the U2OS cells used here. Furthermore, the
actopaxin Quint mutant lacking the Erk phosphorylation
consensus sites cannot be phosphorylated in vivo and sub-
stantially inhibits cell migration, whereas the S4/8D acto-
paxin phosphomimetic mutant demonstrates enhanced mi-
gration compared with WT expressing cells and continues to
extend lamellipodia even in the presence of the Erk inhibi-
tor. The failure of the Quint cells to completely inhibit cell
migration is consistent with the existence of multiple Erk
targets and also to the continued presence of endogenous ac-
topaxin in these cells. In contrast, although the same phos-
phorylation sites on actopaxin are targets for cyclinB/cdc2
kinase in mitotic cells (Curtis et al., 2002), and cyclinB/cdc2
has been shown to regulate cell migration under certain con-
ditions (Manes et al., 2003), pharmacologic inhibitors of
cdc2 activity failed to suppress cell migration in our studies
suggesting that cdc2 phosphorylation of actopaxin is not
playing a significant role in U2OS cells under the conditions
examined.
In summary we have identified actopaxin as an Erk
substrate and determined that inhibition of actopaxin phos-
phorylation, through site-directed mutagenesis, profoundly
inhibits cell adhesion, spreading and cell migration thereby
positioning actopaxin as a potentially important regulator of
cell motility. Future studies will be directed toward determin-
ing actopaxin’s precise role in focal adhesion turnover and ac-
tin dynamics as well as examining whether actopaxin is hyper-
phosphorylated in certain cancer cell populations where it
may contribute to enhanced motility and metastatic potential.
 
Materials and methods
 
Reagents and antibodies
 
Active Erk2 was obtained from New England Biolabs, Inc. Inhibitors for
MEK1 (UO126, PD98059) and cdc2 (alsterpaullone and purvalanol A)
were purchased from Calbiochem. The active MEK1 construct was pur-
chased from Stratagene and the DN MEK1 construct was a gift from M.
Cobb (University of Texas, Southwestern, TX). The N17 Rac construct was
a gift from M. Symons (North Shore Long Island Jewish Research Institute,
Manhasset, NY). Primary antibodies to the Xpress epitope were purchased
from Invitrogen and paxillin (clone 165) were purchased from BD Bio-
sciences. The actopaxin antibody was a gift from Sigma-Aldrich. The Om-
niprobe antibody was purchased from Santa Cruz Biotechnology, Inc. Hu-
man plasma fibronectin was purchased from Sigma-Aldrich, and collagen
type I was purchased from Cohesin.
 
Cell culture and transfection
 
Human osteosarcoma (U2OS) cells were a gift from H. Levinson (Brookdale
University Hospital, Brooklyn, NY). Cells were transfected using FuGene 6
(Roche). Stable transfectants were obtained by growing in media contain-
ing 1 mg/ml G418. Stable transfectants were maintained in DME plus 0.4
mg/ml G418, 10% serum.
 
DNA constructs and mutagenesis
 
Xpress-tagged actopaxin WT was described previously (Nikolopoulos and
Turner, 2000). Actopaxin double point mutant (S4/8D) and Quint mutant
S(4,8,14,19)G/T16A (Quint) were generated using the QuikChange site-
directed mutagenesis kit (Stratagene). The sequences of all mutated con-
structs were verified by sequencing on both strands.
 
In vivo 
 
32
 
P-labeling
 
Actopaxin-expressing cells were washed twice with PBS and then preincu-
bated with 5 ml of phosphate-free DME containing 1% dialyzed FBS for 1 h.
A total of 1.5 
 
 
 
 10
 
6
 
 cells were used for each experimental condition.
The cells were resuspended in 4 ml of media and 500 
 
 
 
Ci of 
 
32
 
Pi (2 mCi/
ml in H
 
2
 
O), and incubated for 1 h at 37
 
 
 
C. Cell suspensions plated on col-
lagen coated dishes for 2 h. Cells were washed two times with PBS and ex-
tracted in 500 
 
 
 
l of lysis buffer (1% NP-40, 50 mM Tris, HCl, pH 7.6, 10%
glycerol, 50 mM NaCl, 0.1% 
 
 
 
-mercaptoethanol, 1 mM PMSF, 10 
 
 
 
g/ml
leupeptin, 5 mM NaF, and 1 mM NaVO
 
4
 
).
To evaluate actopaxin and paxillin phosphorylation, 3 
 
 
 
l of Xpress (or
Omniprobe) or Pax 165 antibody was added to each cell lysate. After 2 h,
protein A/G beads were then added for 2 h at 4
 
 
 
C. Immunocomplexes
were washed four times in lysis buffer before SDS-PAGE. Gels were
stained, dried, and exposed to film.
 
In vitro phosphorylation
 
GST proteins were prepared as described previously (Nikolopoulos and
Turner, 2000). Fusion proteins were washed two times in kinase buffer 
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(New England Biolabs, Inc.) and resuspended in the same buffer. 10 
 
 
 
Ci of
 
 
 
-[
 
32
 
P]ATP and 100 U of recombinant ERK2 were added to each reaction.
After 30 min, the kinase reactions were boiled in sample buffer and run on
a 12.5% gel, dried, and exposed to film.
 
Spreading and motility assays
 
Cells were suspended in 1 ml PBS/EDTA, harvested and washed twice with
serum-free DME,10 
 
 
 
g/ml soybean trypsin inhibitor, 1% BSA. After 1 h in
suspension, cells were replated on 10 
 
 
 
g/ml collagen- or 10 
 
 
 
g/ml fi-
bronectin-coated coverslips in serum-free media for the indicated time pe-
riod, fixed, and processed for indirect immunofluorescence as described
previously (Brown et al., 1996).
Modified Boyden chamber migration assays were performed essentially
as described previously (Riedy et al., 1999). For haptotaxis, an 8-
 
 
 
m pore
membrane was coated on the bottom with 10 
 
 
 
g/ml collagen I. Chemo-
taxis was evaluated by including 25 ng/ml IGF-II in the bottom well. Stim-
ulation of random motility (chemokinesis) was tested by adding 25 ng/ml
IGF-II to the upper well. Scrape wound assays were performed as de-
scribed previously (West et al., 2001). Images were captured every 6 h,
starting at 0 h (
 
t
 
 
 
 
 
 0) after wounding using a microscope (model Eclipse
TE-300; Nikon).
Time-lapse video microscopy for spreading and wound healing assays
was performed as follows. For spreading assays, cells were plated in se-
rum-, phenol-, and bicarbonate-free DME supplemented with 25 mM
Hepes, pH 7.35, on 10 
 
 
 
g/ml collagen-coated plates for 30 min at 37
 
 
 
C.
Images were acquired using a microscope (model Eclipse TE-300; Nikon),
a SPOT camera, and Compix Simple PCI software Imaging. The images
were taken at 1-min intervals for 6–8 h and organized into videos using
Compix Simple PCI 5.0.
 
Online supplemental material
 
Video 1 shows WT actopaxin expressing U2OS cells spreading on a col-
lagen matrix. Video 2 shows Quint actopaxin expressing U2OS cells
spreading on a collagen matrix. Video 3 shows S4/8D actopaxin expressing
U2OS cells spreading on a collagen matrix. Online supplemental material
is available at http://www.jcb.org/cgi/content/full/jcb.200404024/DC1.
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